Cronos Group Inc (CRON)

16.42
0.17 1.02
NASDAQ
Prev Close 16.59
Open 16.60
Day Low/High 16.28 / 16.79
52 Wk Low/High 5.12 / 25.10
Volume 2.85M
Exchange NASDAQ
Shares Outstanding 178.70B
Market Cap 2.91B
Div & Yield N.A. (N.A)
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

Cronos Group's High Times May Be About to Wear Off

Cronos Group's High Times May Be About to Wear Off

Charts of this type are frequently found to be topping patterns.

Altria or Philip Morris International: Which Is the Better Dividend Stock?

Altria or Philip Morris International: Which Is the Better Dividend Stock?

While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.

Use Caution on Small-Caps, Plus Apple, Tesla and McDonald's: Market Recon

Use Caution on Small-Caps, Plus Apple, Tesla and McDonald's: Market Recon

Equity markets marked time on Monday, mostly on light volume.

Cronos Group Certainly Qualifies for Mainstream Consideration

Cronos Group Certainly Qualifies for Mainstream Consideration

Revenue is where it's at for cannabis in 2019.

2 Big Earnings Reports I'll Be Watching This Week

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Short Interest Monitor on Tilray

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.

Chart of the Day: Vetting the Value of Cannabis Companies

Chart of the Day: Vetting the Value of Cannabis Companies

Assessing Aurora and its peers, strictly on the numbers.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz's addition should pacify a persistent critique of the company.

Just How Hot Is Cannabis?

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Aurora's prominent partner could be cannabis' key to breaking into consumer segments.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

Can Cronos Group Soar Higher? Looks Like it

Can Cronos Group Soar Higher? Looks Like it

The stock price of the cannabis company has been on a roll and is poised to move even higher still.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Short-Selling Is Really Hard. Just Ask Citron Research

Short-Selling Is Really Hard. Just Ask Citron Research

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.

Pot Stocks Fade as Momentum Cools

Pot Stocks Fade as Momentum Cools

There are some big shifts Wednesday in names that have recently been the hottest.

Is Apple Aggressively Buying Back Its Stock?

Is Apple Aggressively Buying Back Its Stock?

Without Apple doing so well Monday the indices would look much different.

How Are My Ideas Working Out? January Trade Review (Part 1)

How Are My Ideas Working Out? January Trade Review (Part 1)

Eight of these 11 trade ideas are in the green, with a few big winners.

Cannabis Stocks Are Getting Their Second Wind

Cannabis Stocks Are Getting Their Second Wind

Let's check out the charts of four big names in the space.

Thoughts on Pot

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet

Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.

Real Money Goes Behind the Scenes of the Budding Cannabis Industry

Real Money Goes Behind the Scenes of the Budding Cannabis Industry

In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.

How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco

How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco

What matters here is the ability to innovate, market, and sell.

Who Hasn't Crashed the Cannabis Party Yet?

Who Hasn't Crashed the Cannabis Party Yet?

Establishing who the stragglers are and what impact they might have in the future is the key at this point.

Tilray Is Now a Top-Tier Cannabis Play

Tilray Is Now a Top-Tier Cannabis Play

I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.